Skip to main content

Tweets

Study of 151,305 pts from Clinical Practice Research Datalink, shows that THR/TKR patients exposed to statins for 1-5 years had ~25% reduced risk of arthroplasty revision (HR 0.74 (0.62, 0.88)). https://t.co/AQhKHuAwkD

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Pain signaling via NMDA receptors in the brain can be treated with drugs that block NMDA receptors (ketamine, methadone, memantine, amantadine, dextromethorphan). Metanalysis of memantine (15 studies) shows little benefit. https://t.co/72yfYzDXhV

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Brain fog (Fibro Fog) is common with sleep disorders and fibromyalgia. Manifests as memory problems, poor mental focus, forgetfulness - all correctable with sleep medicine evaluation and sleep assistance. https://t.co/e6CXXkYV39

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Study of 21,016 SLE patients from Korean Health Claims databases shows SLE patients have a higher risk of cancer than controls (OR 1.44; 95% CI 1.33–1.56) with highre rates of cervical, thyroid, ovarian, oral cancer, lymphoma, leukemia, & multiple myeloma https://t.co/NKR9i4ccfU

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Time to register for this weeks RheumNow Live. Free online streaming video - 16 hrs of Innovative lectures and Q&A Panels from friday afternoon 3/22, till noon Sunday 3/24. Register for FREE at https://t.co/wIgS5rq4UE

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
QD Clinic - When To Stop MTX- Should/Can a Patient ever stop MTX? | RheumNow https://t.co/z0Dhwdbr3Q

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
European Commission Approves MabThera (rituximab) for use in Pemphigus, US FDA approved it in 6/18; RTX is now approved in 4 autoimmune disorders in the US & Europe (RA, GPA, MPA, Pemphigus) - Not approved for use in children https://t.co/dJJfPdXuWQ(rituxim/364143/index.html

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Nice comprehensive full read review of the Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline from the JBMR. https://t.co/Eh9xfPJ2B0

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Vedolizumab superior to adalimumab in clinical remission (31 vs 22%) and mucosal healing(40 vs 28%) at week 52 when given to383 patients with moderate to severely active ulcerative colitis. Data presented at European Crohn’s and Colitis Congress. https://t.co/dXrEkzhnKh

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
Daily noninvasive ultrasound (US) stimulation of the spleen significantly reduces disease severity in a murine model of inflammatory arthritis. Results mediated via T & B cell effects as T/B deficient mice did not improve with splenic US. https://t.co/dSlYWEgplR

Dr. John Cush @RheumNow ( View Tweet )

7 years 4 months ago
The Weekly RheumNow Podcast is up! https://t.co/qA4wADpPN8 or listen to it on iTunes or SoundCloud https://t.co/mZ3y0yvwA3

Dr. John Cush @RheumNow ( View Tweet )

7 years 5 months ago
FREE-Register to view into RheumNow Live next friday 3/22 >> https://t.co/lbrJ0Dp1Hb AFabulous Faculty - Calabrese, O'Shea, Weinblatt, Ruderman, Reveille, Langford, Seo, Kavanaugh, Conaghan, VanVollenhoven, Schett, Matteson, Wolfe, Pincus & more https://t.co/0NwHXWfjyO

Dr. John Cush @RheumNow ( View Tweet )

7 years 5 months ago
2,933 adults >50 yrs went to the ER with a new vertebral fracture (2008-2014) but 98% did not have a DXA in 2yrs before and 1 yr after; and only 7% started OP Rx; In the ensuing 2 yrs, 38% developed another Fx https://t.co/JYYLFawV5z

Dr. John Cush @RheumNow ( View Tweet )

7 years 5 months ago
QD44 - RA and Gout https://t.co/5a4rtwt1dw via @YouTube

Dr. John Cush @RheumNow ( View Tweet )

7 years 5 months ago
#1 Humira tops list of top selling drugs of 2018 at $19.9 Billion worldwide sales. Other Rheum drugs include #6 Rituxan $6.9 billion and #10 Stelara $5.2 billion https://t.co/mj5nTIQHL0

Dr. John Cush @RheumNow ( View Tweet )

7 years 5 months ago
×